Vilin Bio Med Limited Share Price & Stock Analysis

Vilin Bio Med Limited (NSE: VILINBIO) is a Hyderabad, Telangana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹79 Cr, it ranks #3,425 by market cap among the 6,197 Indian listed companies on FinBizNet, and #46 of 63 in Pharmaceuticals. At ₹52.00 (as of 16 Nov 2026), the share price is 14.7% below its 52-week high of ₹60.95 and 174.4% above its 52-week low of ₹18.95. The share price is up 99.6% over one year and up 26.3% over three months.

Key Metrics

Current Price₹52.00
Market Cap₹79 Cr
NSE SymbolVILINBIO
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio41.3
Return on Equity7.51%
Return on Assets5.80%
52-Week Range₹18.95 – ₹60.95
1-Year Price Change+99.6%
3-Month Price Change+26.3%
Beta (1Y)0.52
HeadquartersHyderabad, Telangana
Websitewww.vilinbiomed.co.in

Shareholding and Delivery

Promoters held 56.65% of Vilin Bio Med Limited's shares as of Jun 2026, against 63.89% in Sept 2025 (−7.24 percentage points).

About Vilin Bio Med Limited

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non beta lactam tablets and capsules, and nutritional food supplements. It sells its products in bulk to pharmaceuticals manufacturers, marketers, and traders. Vilin Bio Med Limited was incorporated in 2005 and is based in Hyderabad, India.

Products and Services

1. Pharmaceuticals-This segment manufactures and sells pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmaceuticals-100%

Vilin Bio Med Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Vilin Bio Med Limited₹79 Cr41.37.51%—+99.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Vilin Bio Med Limited?

Vilin Bio Med Limited is trading at ₹52.00, with a market capitalisation of ₹79 Cr.

Which sector does Vilin Bio Med Limited belong to?

Vilin Bio Med Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Vilin Bio Med Limited?

Vilin Bio Med Limited has a P/E of 41.3 and a return on equity of 7.51%.

What is the stock symbol of Vilin Bio Med Limited?

Vilin Bio Med Limited is listed on the NSE under the symbol VILINBIO.

How has Vilin Bio Med Limited's share price moved over the past year?

Vilin Bio Med Limited's share price is up 99.6% over one year and up 26.3% over three months. Its 52-week range is ₹18.95 to ₹60.95.

What is the promoter holding in Vilin Bio Med Limited?

Promoters held 56.65% of Vilin Bio Med Limited's shares as of Jun 2026, against 63.89% in Sept 2025 (−7.24 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.